Vigantoletten for Vitamin D Deficiency

This active ingredient is in Vigantoletten

Vigantoletten contain colecalciferol (vitamin D3) as the active ingredient. It regulates the calcium level in the blood and bones by stimulating proteins that are involved in calcium transport and calcium metabolism. In this way, the ingredient maintains the balance between bone formation and bone resorption. The preparation ensures that the daily requirement of vitamin D3 is covered and thus helps with metabolic disorders. In the Fluor-Vigantoletten, this active ingredient is combined with fluorine. This combination has proven effective as a preventive measure against tooth decay and rickets.

When are Vigantoletten used?

Vigantoletten are used for

  • Calcification disorders of the bone apparatus in children (rickets)
  • Vitamin D deficiency, which can be associated with tiredness, fatigue and frequent infections
  • Osteoporosis (excessive breakdown of bone tissue)
  • Dental caries

The use of Vigantoletten is possible for

  • Bone softening in adults (equivalent to rickets in children)
  • Hypofunction of the parathyroid glands (hypoparathyroidism)

What are the side effects of Vigantoletten?

If the sometimes very serious side effects of Vigantoletten occur or if other, unspecified complaints are observed, always consult a doctor.

What you should bear in mind when using Vigantoletten

Vigantoletten must not be taken if:

  • existing hypersensitivity to the active substance or other components of Vigantoletten or Fluor-Vigantoletten
  • an increased concentration of calcium in the blood or urine (hypercalcemia or hypercalciuria)

Vigantoletten should only be prescribed with particular caution if:

  • kidney function is impaired (tendency to form kidney stones)
  • mobility is restricted (bone fractures, paralysis, etc.)
  • a systemic disease of the connective tissue (sarcoidosis) is present

To prevent unwanted drug interactions, please inform your doctor or pharmacist if you are taking medication at the same time. The effect of the following drugs may impair the potency of Vigantoletten:

  • Drugs used to treat epilepsy and severe sleep disorders and to induce anesthesia (phenytoin, barbiturates)
  • Glucocorticoids for the treatment of allergic reactions
  • Agents to promote urination (benzothiadiazine derivatives)

Children and adolescents

The safe administration of the drug in children is based on certain daily dose limits of Vigantoletten:

  • Babies up to one year: 1000 I.U. (international unit, unit of measurement in medicine)
  • Children from one to ten years: 2000 I.U.
  • Children between eleven and 17 years: 4000 I.U.

However, the exact dosage should be determined by a doctor or pharmacist in each individual case.

If long-term treatment is necessary, the blood values should be checked regularly. The dosage can be adjusted on the basis of these values.

For infants and small children, the tablet is dissolved on a teaspoon with a little water. The medicine should not be added to baby bottles or porridge or only after the food has been cooked. Adults should take the tablets or coated tablets with sufficient liquid.

Overdose

The symptoms of poisoning with Vigantoletten or Fluor-Vigantoletten are relatively unspecific. Nausea, vomiting, diarrhea, constipation, headache, muscle and joint pain, muscle weakness or drowsiness, increased thirst and, later on, dehydration are possible. The blood laboratory values are typically altered. A doctor should always be consulted if these signs occur.

Pregnancy and breastfeeding

The active ingredient passes into breast milk, but no negative effects have been observed in children when used as directed.

How to obtain Vigantoletten

Vigantoletten are available from pharmacies without a prescription. The pharmacist can advise on the most suitable preparation.

Complete information about this medicine

Here you will find the complete information on the medication as a download (PDF)